Therapeutic compounds for treating dyslipidemic conditions
申请人:Merck & Co., Inc.
公开号:US07125865B2
公开(公告)日:2006-10-24
The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.
NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE
申请人:Maeda Kazuhiro
公开号:US20130040930A1
公开(公告)日:2013-02-14
Provided are a novel low-molecular-weight compound that suppresses production of induction type MMPs, particularly MMP-9, rather than production of hemostatic type MMP-2, as well as a prophylactic/therapeutic drug for autoimmune diseases or osteoarthritis. An amide derivative represented by the following formula (I)
wherein each symbol is as defined in the specification, or a pharmacologically acceptable salt thereof.
Provided are a novel low-molecular-weight compound that suppresses production of induction type MMPs, particularly MMP-9, rather than production of hemostatic type MMP-2, as well as a prophylactic/therapeutic drug for autoimmune diseases or osteoarthritis. An amide derivative represented by the following formula (I)
wherein each symbol is as defined in the specification, or a pharmacologically acceptable salt thereof.
Cu-catalyzed <i>N</i>-3-Arylation of Hydantoins Using Diaryliodonium Salts
作者:Linn Neerbye Berntsen、Ainara Nova、David S. Wragg、Alexander H. Sandtorv
DOI:10.1021/acs.orglett.0c00642
日期:2020.4.3
A general Cu-catalyzed, regioselective method for the N-3-arylation of hydantoins is described. The protocol utilizes aryl(trimethoxyphenyl)iodonium tosylate as the arylating agent in the presence of triethylamine and a catalytic amount of a simple Cu-salt. The method is compatible with structurally diverse hydantoins and operates well with neutral aryl groups or aryl groups bearing weakly donating/withdrawing
A versatile synthesis of 1,4-benzodiazepine derivatives through the reaction of various 3-(trifluoromethanesulfonyloxy)benzynes with N-(p-toluenesulfonyl)imidazolidin-2-ones is reported. This reaction system provides a 1,4-benzodiazepine bearing a trifluoromethanesulfonyloxy group as a single regioisomer among the four possible regioisomers.